India is known as the “Thalassemia capital of the world.” It has the highest number of patients with thalassemia major in the world. India has around 50 million (5 crore) carriers of the ß ...

During her visit to Ganja on March 6, First Vice-President and President of the Heydar Aliyev Foundation Mehriban Aliyeva, ...

PalTech inaugurated its new office in Gachibowli, Hyderabad, this February, marking a significant milestone in its growth ...

NTR Memorial Trust building construction in Vijayawada to enhance public service accessibility with blood bank and ...

Editas Medicine, Inc.’s EDIT share price has surged by 16.48%, which has investors questioning if this is right time to sell.

For thousands of Indians suffering from blood cancers and blood-related disorders such as thalassemia and aplastic anemia, a ...

The following is a summary of “Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations ...

Smart Solutions for Preventive and Complex Pediatric Care Conforming to International Standards—Ensuring a Healthier Future ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...

We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.